Joost Alexander Kolkman
Ablynx
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Joost Alexander Kolkman.
Drug Discovery Today: Technologies | 2010
Joost Alexander Kolkman; Debbie A. Law
Antibodies have been a focus of drug development since the approval of Orthoclone® OKT3 in 1986. However these large biologics are not without limitations. This has led to new technologies which harness the power of the immune system but provide distinct advantages over conventional antibody approaches. Nanobodies® are llama-derived proteins with unique characteristics well suited for drug discovery. The Nanobody platform has proven robust with four Nanobodies currently in clinical development.
Archive | 2007
Joost Alexander Kolkman; Els Beirnaert
Archive | 2007
Hilde Revets; Joost Alexander Kolkman; Hendricus Renerus Jacobus Mattheus Hoogenboom
Archive | 2007
Joost Alexander Kolkman
Archive | 2007
Els Beirnaert; Joost Alexander Kolkman; Hendricus Renerus Jacobus Matteus Hoogenboom
Archive | 2010
Els Beirnaert; Cedric Jozef Neotere Ververken; Joost Alexander Kolkman; Roy Maarten Van
Archive | 2014
Joost Alexander Kolkman; Els Beirnaert
Archive | 2010
Els Beirnaert; Cedric Jozef Neotere Ververken; Joost Alexander Kolkman; Maarten Van Roy
Archive | 2014
Els Beirnaert; Cedric Jozef Neotere Ververken; Joost Alexander Kolkman; Maarten Van Roy
Archive | 2008
Joost Alexander Kolkman
